Akt-the mammalian target of rapamycin (mTOR) pathway inhibition increases cervical cancer cell chemosensitivity to active form of irinotecan (SN-38)

2 1 10 Akt-the mammalian target of rapamycin (mTOR) pathway inhibition increases cervical cancer cell chemosensitivity to active form of irinotecan (SN-38) FARIED, Ahmad Additional Author ARIFIN, Muhammad Zafrullah Additional Author SUTIONO, Agung Budi Primary Author OHIRA, Takayuki Additional Author mixed material 23021381 Bandung Fak. Kedokteran UNPAD 2013 mTORC1 inhibition induces pain via IRS-1-dependent feedback activation of ERK SORGE, Robert E. Additional Author KHOUTORSKY, Arkady Additional Author YAN, Jin Additional Author Asiedu, Marina N. [et.al] Additional Author MELEMEDJIAN, Ohannes K. Primary Author mixed material 03043959 Washington DC IASP 2013